Cargando…
Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
Limited efficacy of current therapeutic approaches for neurodegenerative disease has led to increased interest in alternative therapies. Cord blood plasma (CBP) derived from human umbilical cord blood (hUCB) may be a potential therapeutic. Benefits of CBP injection into rodent models of aging or isc...
Autores principales: | Ehrhart, Jared, Sanberg, Paul R., Garbuzova‐Davis, Svitlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237605/ https://www.ncbi.nlm.nih.gov/pubmed/30334335 http://dx.doi.org/10.1111/jcmm.13898 |
Ejemplares similares
-
Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008) -
Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2018) -
Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2012) -
Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014) -
Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model
por: Lee, Jea‐Young, et al.
Publicado: (2019)